The purpose of this award is to provide supplementary funding during the pilot/exploratory phase of basic, translational or clinical research projects in autoimmune liver disease (e.g., autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis) in preparation for future grant applications by the recipient. Projects should address focused research questions pertaining to the pathogenesis, diagnosis, management, or outcome of autoimmune liver diseases in children and adults.
Additional dedicated funding to advance research activities in autoimmune hepatitis is available for the 2024 Awards cycle. Applications in autoimmune hepatitis are encouraged in all early to mid-career research award categories and the Pilot and Autoimmune Exploratory Research Award categories.
Application Deadline: December 4, 2023